Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
231.8 USD | +0.48% | +5.80% | +12.85% |
Jun. 03 | Cencora Insider Sold Shares Worth $419,506, According to a Recent SEC Filing | MT |
May. 30 | Cencora, Inc. Revises Earnings Guidance for the Fiscal Year 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.16 for the 2024 fiscal year.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.85% | 45.64B | B- | ||
-6.21% | 180B | C+ | ||
-0.08% | 108B | C | ||
-3.09% | 68.29B | A | ||
-4.84% | 46.96B | B- | ||
+7.77% | 42.41B | B+ | ||
+19.71% | 31.01B | B | ||
+16.55% | 25.51B | A- | ||
-7.44% | 23.17B | B | ||
-9.78% | 23.14B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- COR Stock
- Ratings Cencora, Inc.